Le Lézard
Classified in: Health
Subject: SVY

Global Wound Closure Devices Market to Grow at a CAGR of 6.4% by 2021: Increasing Volume of Surgical Procedures


DUBLIN, August 18, 2017 /PRNewswire/ --

The "Global Wound Closure Devices Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global wound closure devices market to grow at a CAGR of 6.42% during the period 2017-2021

Global Wound Closure Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is advancements in wound care technologies. The wound care industry is expected to experience massive growth in the future due to increasing number of chronic injuries and surgeries. The growing cases of chronic injuries increase the demand for wound closure devices with an advanced and effective breakthrough in wound care and healing technology.

According to the report, one driver in the market is increasing volume of surgical procedures. Surgical procedures are the medical interventions, which create an incision or small wound at the location where surgery is performed in the patient's body. There is an increasing incidence of cardiovascular, orthopedic, gynecological, general, and ophthalmic surgeries, which result in the rise in demand for wound closure devices as it is designed to aid the wound and manipulate the edges of the wound tissue by closing the tissues together.

Further, the report states that one challenge in the market is high technical requirements for utilization of wound closure devices. Wound healing is a natural phenomenon. However, if the tissue is severely damaged, it requires external support to heal faster. Technical assistance from the highly skilled professionals to utilize the wound closure device efficiently is essential for fast and safe recovery of the wounds. The improper usage of wound closure device may result in tissue damage, discomfort to the patient, and high chances of developing an infection.

Key Vendors

Other Prominent Vendors

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by end-users

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

PART 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/bgxvcg/global_wound

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: